Company news
Whitehawk Therapeutics, Inc. news in 2025
Whitehawk Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
December 1, 2025
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
November 11, 2025
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 6, 2025
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
October 24, 2025
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
September 2, 2025
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
August 7, 2025
Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 22, 2025
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series
June 19, 2025
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference
May 28, 2025
Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit
May 21, 2025
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights
May 8, 2025
Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals
March 26, 2025
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
March 13, 2025
Aadi Bioscience Announces Closing of $100 Million PIPE Financing
March 3, 2025
Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
March 2, 2025
Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
February 23, 2025
Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer
February 17, 2025
Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025
February 4, 2025